580. Clinical treatment pathways of antipsychotics in patients with schizophrenia spectrum disorder: a retrospective longitudinal observational study

Q Bo, T Li, Y Wang, Z Liu · 2026

Read 580. Clinical treatment pathways of antipsychotics in patients with schizophrenia spectrum disorder: a retrospective longitudinal observational study by Q Bo, T Li, Y Wang, Z Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13556588.txt.

Description

Bo and colleagues traced the order in which schizophrenia patients receive antipsychotic drugs in real hospital care. Trials say little about the paths patients actually follow after a first episode. Knowing those paths matters for spotting treatment resistance early. Late use of clozapine, the last-resort drug, is a known concern.

The team rebuilt drug histories for over three thousand patients at a psychiatric hospital. Five drugs made up nearly all first choices, led by quetiapine at about a third of starts. Switches mostly stayed inside the same five drugs. Among children, aripiprazole ranked first instead. Only twenty-seven patients started clozapine within a year of care. The authors argue that such pathway maps can guide more personal, timely care.

Catalog record

CREATORQ Bo, T Li, Y Wang, Z Liu
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE3 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13556588

Browse the full library · About the Tower of Babel